OSL — Oncosil Medical Cashflow Statement
0.000.00%
Last trade - 00:00- AU$24.10m
- AU$19.06m
- AU$1.26m
Annual cashflow statement for Oncosil Medical, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Changes in Working Capital | 2.99 | 0.842 | 0.884 | 1.17 | 1.14 |
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -8.82 | -10.1 | -11.3 | -10.8 | -12.1 |
| Capital Expenditures | -0.054 | -0.006 | -0.058 | -0.197 | -0.015 |
| Purchase of Fixed Assets | |||||
| Cash from Investing Activities | -0.054 | -0.006 | -0.058 | -0.197 | -0.015 |
| Financing Cash Flow Items | 0 | — | — | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.111 | 9.16 | 9.49 | 6.13 | 12.7 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -8.76 | -0.96 | -1.89 | -4.89 | 0.608 |